PortfoliosLab logoPortfoliosLab logo
IDR vs. ZVRA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IDR vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Idaho Strategic Resources, Inc. (IDR) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDR achieves a -23.67% return, which is significantly lower than ZVRA's 49.00% return. Over the past 10 years, IDR has outperformed ZVRA with an annualized return of 33.74%, while ZVRA has yielded a comparatively lower -14.94% annualized return.


IDR

1D
-0.55%
1M
-10.87%
6M
-37.07%
YTD
-23.67%
1Y
83.53%
3Y*
75.61%
5Y*
44.40%
10Y*
33.74%

ZVRA

1D
-4.23%
1M
2.93%
6M
57.24%
YTD
49.00%
1Y
6.54%
3Y*
40.34%
5Y*
0.06%
10Y*
-14.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDR vs. ZVRA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IDR
Idaho Strategic Resources, Inc.
-23.67%295.49%60.95%11.07%-23.39%102.06%93.38%-15.00%5.26%26.67%
ZVRA
Zevra Therapeutics Inc.
49.00%7.43%27.33%42.70%-47.30%-22.23%84.70%-78.71%-56.05%37.29%

Correlation

The correlation between IDR and ZVRA is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.03

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2015

0.03

The correlation between IDR and ZVRA shifts across timeframes, from 0.03 (10 years) to 0.16 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

IDR:

$486.31M

ZVRA:

$789.19M

EPS

IDR:

$1.41

ZVRA:

$2.15

PE Ratio

IDR:

21.82

ZVRA:

6.21

PS Ratio

IDR:

9.42

ZVRA:

6.31

PB Ratio

IDR:

4.21

ZVRA:

3.91

Total Revenue (TTM)

IDR:

$49.61M

ZVRA:

$122.29M

Gross Profit (TTM)

IDR:

$23.05M

ZVRA:

$104.94M

EBITDA (TTM)

IDR:

$24.61M

ZVRA:

$149.15M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDR vs. ZVRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDR
IDR Risk / Return Rank: 7575
Overall Rank
IDR Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
IDR Sortino Ratio Rank: 7575
Sortino Ratio Rank
IDR Omega Ratio Rank: 7272
Omega Ratio Rank
IDR Calmar Ratio Rank: 7777
Calmar Ratio Rank
IDR Martin Ratio Rank: 7474
Martin Ratio Rank

ZVRA
ZVRA Risk / Return Rank: 5252
Overall Rank
ZVRA Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
ZVRA Sortino Ratio Rank: 5252
Sortino Ratio Rank
ZVRA Omega Ratio Rank: 5252
Omega Ratio Rank
ZVRA Calmar Ratio Rank: 5353
Calmar Ratio Rank
ZVRA Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDR vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Idaho Strategic Resources, Inc. (IDR) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IDRZVRADifference
Sharpe ratioReturn per unit of total volatility

+0.85

Sortino ratioReturn per unit of downside risk

+1.02

Omega ratioGain probability vs. loss probability

1.21

1.09

+0.12

Calmar ratioReturn relative to maximum drawdown

1.81

0.26

+1.56

Martin ratioReturn relative to average drawdown

3.58

0.45

+3.13

IDR vs. ZVRA - Sharpe Ratio Comparison

The current IDR Sharpe Ratio is 1.04, which is higher than the ZVRA Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of IDR and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IDR vs. ZVRA - Drawdown Comparison

The maximum IDR drawdown since its inception was -93.44%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for IDR and ZVRA.


Loading charts...

Drawdown Indicators


IDRZVRADifference

Max Drawdown

Largest peak-to-trough decline

-93.44%

-99.27%

+5.83%

Max Drawdown (1Y)

Largest decline over 1 year

-49.96%

-43.47%

-6.49%

Max Drawdown (3Y)

Largest decline over 3 years

-49.96%

-43.47%

-6.49%

Max Drawdown (5Y)

Largest decline over 5 years

-62.42%

-66.94%

+4.52%

Max Drawdown (10Y)

Largest decline over 10 years

-62.42%

-97.85%

+35.43%

Current Drawdown

Current decline from peak

-41.59%

-96.47%

+54.88%

Average Drawdown

Average peak-to-trough decline

-47.21%

-86.47%

+39.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.27%

24.89%

+0.38%

Volatility

IDR vs. ZVRA - Volatility Comparison

Idaho Strategic Resources, Inc. (IDR) has a higher volatility of 19.21% compared to Zevra Therapeutics Inc. (ZVRA) at 12.44%. This indicates that IDR's price experiences larger fluctuations and is considered to be riskier than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDRZVRADifference

Volatility (1M)

Calculated over the trailing 1-month period

19.21%

12.44%

+6.77%

Volatility (6M)

Calculated over the trailing 6-month period

60.99%

40.65%

+20.34%

Volatility (1Y)

Calculated over the trailing 1-year period

89.84%

61.17%

+28.67%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.07%

60.33%

+12.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.79%

80.82%

+4.97%

Dividends

IDR vs. ZVRA - Dividend Comparison

Neither IDR nor ZVRA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IDR vs. ZVRA - Financials Comparison

This section allows you to compare key financial metrics between Idaho Strategic Resources, Inc. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
14.48M
36.22M
(IDR) Total Revenue
(ZVRA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IDR and ZVRA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDR has higher volatility (19.21%) compared to ZVRA (12.44%). In terms of maximum drawdown, IDR dropped -93.44% vs ZVRA's -99.27%.

IDR currently has the higher Sharpe Ratio (1.04 vs 0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDR and ZVRA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer